Cognoa, a Palo Alto, CA-based digital health startup has raised $11.6 million in funding led by existing investor Morningside to advance earlier diagnosis of development delays in children. The company plans to utilize the funding to advance Cognoa's machine-learning-based technology; support additional clinical validation and the U.S. Food and Drug Administration (FDA) submissions and approvals process; and expand commercialization with employers, payers and clinicians. Cognoa has raised a
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
